REGOMA-OSS: 반복성 교모세포종 환자에서 레고라페닙의 효능과 안전성을 평가하는 대규모 이탈리아 다기관 전향적 관찰 연구

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Observational real-life study on regorafenib in recurrent glioblastoma: does dose reduction reduce toxicity while maintaining the efficacy?2022 · 19 citations
2. 2Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma2020 · 1,473 citations
3. 3CTCAE versión 5.0. Evaluación de la gravedad de los eventos adversos dermatológicos de las terapias antineoplásicas2020 · 850 citations
4. 4Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma2005 · 21,716 citations
5. 5CTNI-85. GBM AGILE PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GBM: RESULTS OF FIRST EXPERIMENTAL ARM, REGORAFENIB2023 · 18 citations